Insider Transactions in Q1 2025 at Rezolute, Inc. (RZLT)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2025
|
Wladimir Hogenhuis |
BUY
Open market or private purchase
|
Direct |
6,758
+7.44%
|
$13,516
$2.92 P/Share
|
|
Mar 27
2025
|
Nevan C Elam CEO |
BUY
Open market or private purchase
|
Direct |
12,302
+5.2%
|
$24,604
$2.85 P/Share
|
|
Mar 26
2025
|
Daron Evans CFO |
BUY
Open market or private purchase
|
Indirect |
10,000
+30.3%
|
$20,000
$2.88 P/Share
|
|
Mar 26
2025
|
Daron Evans CFO |
BUY
Open market or private purchase
|
Direct |
10,000
+4.03%
|
$20,000
$2.89 P/Share
|
|
Feb 18
2025
|
Wladimir Hogenhuis |
BUY
Open market or private purchase
|
Direct |
10,000
+11.46%
|
$40,000
$4.7 P/Share
|
|
Feb 16
2025
|
Wladimir Hogenhuis |
BUY
Grant, award, or other acquisition
|
Direct |
25,500
+27.49%
|
-
|
|
Feb 16
2025
|
Gil M Labrucherie |
BUY
Grant, award, or other acquisition
|
Direct |
25,500
+50.0%
|
-
|
|
Feb 16
2025
|
Daron Evans CFO |
BUY
Grant, award, or other acquisition
|
Direct |
77,000
+25.25%
|
-
|
|
Feb 16
2025
|
Young Jin Kim |
BUY
Grant, award, or other acquisition
|
Direct |
25,500
+15.32%
|
-
|
|
Feb 16
2025
|
Nerissa Kreher |
BUY
Grant, award, or other acquisition
|
Direct |
25,500
+50.0%
|
-
|
|
Feb 16
2025
|
Brian Kenneth Roberts Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
77,000
+36.96%
|
-
|
|
Feb 16
2025
|
Nevan C Elam CEO |
BUY
Grant, award, or other acquisition
|
Direct |
204,000
+49.06%
|
-
|
|
Feb 16
2025
|
Philippe Fauchet |
BUY
Grant, award, or other acquisition
|
Direct |
25,500
+50.0%
|
-
|